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Abstract
Cardiac resynchronization therapy (CRT) is electrical resynchronization of the ventricles.
Bachmann’s bundle (BB) pacing is considered to be electrical resynchronization of the atria.
Atrial fibrillation (AF) and congestive heart failure (HF) often coexist in the same patient.
A 69 year-old man who underwent CRT combined with BB pacing for HF and atrial
tachycardias or atrial fibrillation (AF) improved HF symptoms. The combined therapy re-
duced the number of admissions and occurrence of atrial tachyarrhythmias. It is possible that
CRT combined with BB pacing could provide synergistic, beneficial effects on symptoms in
patients with HF and AF and hence break a vicious circle. (Cardiol J 2009; 16, 4: 358–361)
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Introduction
Cardiac resynchronization therapy (CRT) is
electrical resynchronization of the ventricles. Bach-
mann’s bundle (BB) pacing is considered to be elec-
trical resynchronization of the atria. The synergis-
tic effects of CRT and BB pacing have yet to be
determined in patients with atrial tachyarrhythmi-
as and heart failure (HF).
Case report
A 69 year-old man was admitted with dyspnea
on exertion and palpitations. He underwent aortic
valve replacement for aortic regurgitation due to
rheumatic fever at the age of 32 and was re-operat-
ed upon at the age of 57. Body surface electrocar-
diography demonstrated left bundle branch block,
a superior QRS axis and prolonged QRS duration,
200ms during sinus rhythm (Fig. 1A). Echocardio-
graphy revealed left ventricular (LV) dilatation,
62 mm, and dyssynchrony with a low LV ejection
fraction, 0.34 and mild mitral valve regurgitation.
He was admitted several times to treat congestive
HF and atrial tachycardias. He underwent catheter
ablation for refractory atrial tachycardias. Two dif-
ferent re-entrant atrial tachycardias were induced
by programmed atrial extra-stimuli. The atrial tach-
ycardias were terminated by catheter ablation of
cavo-tricuspid isthmus and point-by point ablation
with an entrainment mapping technique.
He experienced a recurrence of HF with par-
oxysmal atrial fibrillation (AF) several months af-
ter the ablation of atrial tachycardias. His symptoms
increased to NYHA class IV and quality of life de-
teriorated despite optimized medical therapy in-
cluding loop diuretics, spironolactone, digoxin, beta-
-blocker, angiotensin receptor blocker and admi-
nistration of intravenous inotropic agents. He needed
lengthy hospitalization with the increased symptoms.
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Hemodynamic data revealed pulmonary capillary
wedge pressure was 29 mm Hg and pulmonary ar-
tery pressure 50/20 mm Hg. Echocardiography
showed further deterioration of LV ejection fraction.
He qualified for implantation of CRT for HF. The
target site for the left ventricular pacing lead was
a postero-lateral tributary of the coronary sinus. The
coronary sinus lead was connected to a CRT pace-
maker (InSync model 8040, Medtronic Inc, Minne-
apolis, MN, USA). The patient received the bipolar
atrial screw-in pacing lead in Bachmann’s bundle
region, atrial septal site and a standard right ven-
tricular pacing lead. The CRT pacemaker was pro-
grammed in biventricular DDD mode with a lower
rate of 70 beats/min and atrio-ventricular delay was
150 ms. electrocardiography revealed a shortened
QRS width of 120 ms after the initiation of CRT
(Fig. 1B). P wave duration also decreased when
atrial pacing was performed, compared with the
control. Clinical improvement was observed from
NYHA class IV to NYHA class II within two weeks
(Fig. 2). Chest X-ray showed an improvement of con-
gestive HF (Fig. 3). The serum brain natriuretic pep-
tide level decreased from over 400 to less than
250 pg/mL two months after the CRT implantation
(Fig. 2). No paroxysmal AF or atrial tachyarrhyth-
mias occurred after the combined CRT and BB pa-
cing (Fig. 2). Thus, no more inotropic agents were
needed and he was discharged after cardiac reha-
bilitation. He has been followed up for one year
without an admission for HF or tachyarrhythmias.
Ambulatory pacemaker monitoring during follow-
-up disclosed no incidence of AF or atrial tachyar-
rhythmias except for asymptomatic episodes of atrial
ectopic beats.
Discussion
In our case study, the CRT and BB pacing sig-
nificantly improved symptoms of severe HF and
prevented atrial tachyarrhythmias and paroxysmal
AF. The combined therapies could enhance each
pacing effect on improving symptoms of HF and
preventing atrial tachyarrhythmias.
CRT is an effective adjunctive therapy for the
treatment of symptomatic moderate and severe HF
[1]. CRT not only increases the likelihood of clini-
cal improvement, but also reduces the risk of cli-
nical deterioration during the course of follow-up.
AF and CHF often co-exist in the same patient and
constitute a vicious circle in which CHF promotes
AF and AF aggravates CHF. However, a CRT de-
vice is less effective in terms of the suppression of
atrial tachyarrhythmias or AF. Padeletti et al. [2]
first examined whether AF suppression algorithm
to CRT improved the prognosis of patients. They
suggested that CRT combined with a refined pac-
ing algorithm represented a major advance in the
management of AF and CHF by electrical stimula-
tion. Fung et al. [3] reported that patients with CRT
had a significantly lower incidence of AF than con-
trols. Other reports have on the contrary shown that
Figure 1. 12-lead electrocardiography demonstrates the QRS width before (A) and after (B) cardiac resynchronization
therapy (CRT) pacemaker implantation. QRS width has shortened from 200 to 120 ms.
Control CRT
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CRT did not influence the incidence of AF [4, 5].
Atrioventricular (A-V) junction ablation and pacing
are commonly performed in CRT candidates with
chronic AF. As for paroxysmal AF, effective pacing
algorithm and pacing site should be introduced as
a therapeutic option.
Studies had reported that BB pacing could pre-
vent paroxysmal AF [6, 7]. The prevention of AF
could be associated with BB pacing which causes
a shorter total atrial activation time and less in-
teratrial conduction delay. Furthermore, atrial sep-
tal pacing decreases dispersion of refractoriness,
Figure 2. Serum brain natriuretic peptide (BNP) level during clinical course and duration of admission, occurrence of
paroxysmal atrial fibrillation (AF), atrial tachycardias (AT) and NYHA class before and after cardiac resynchronization
therapy (CRT) combined with Bachmann’s bundle (BB) pacing implantation. The BNP decreased after CRT implanta-
tion and symptoms improved without paroxysmal AF and AT.
Figure 3. Chest X-ray shows an improvement of congestive heart failure before (A) and after (B) cardiac resynchroni-
zation therapy and Bachmann’s bundle pacing implantation; RV — right ventricle, LV — left ventricle.
Control CRTA B
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which may be preferable in patients with paroxy-
smal AF.
CRT provides proper detection of atrial signals
and reliable atrial pacing when effective A-V syn-
chronous pacing is feasible. In addition to the A-V
and V-V synchronicity of CRT, BB pacing could lead
to an appropriate A-A synchronicity and represent
a significant advance in the management of AF and
severe HF patients.
In conclusion, the CRT combined with BB pac-
ing has improved symptoms of HF and reduced
number of admissions and occurrence of atrial tachy-
arrhythmias. It is possible that CRT combined with
BB pacing could provide synergistic, beneficial ef-
fects on symptoms in patients with HF and AF, thus
breaking the vicious circle.
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